Pharvaris
Maggie Beller currently holds the role of Executive Director at Pharvaris since May 2022. Prior to this, Maggie worked at Russo Partners, LLC where Maggie held various positions including Vice President and Assistant Vice President. Before that, Maggie was a Recruiter at Real Staffing and worked as a chemist at Immucor, Inc. Maggie also has experience as a Laboratory Assistant at Rensselaer Polytechnic Institute. Maggie holds a Bachelor of Science degree in Chemistry from the same institute.
This person is not in any teams
This person is not in any offices
Pharvaris
2 followers
Pharvaris is a preclinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (HAE) and other B2 receptor-mediated indications. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.